Scienjoy Holding financials
$0.6769+4.14%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $177.5M | $186.8M | $206.9M | $283.2M | $262.6M | $187.3M |
| Gross profit | $32.5M | $33.6M | $27.2M | $41.1M | $47.9M | $40.2M |
| Gross margin | 18.3% | 18.0% | 13.2% | 14.5% | 18.2% | 21.5% |
| Operating income | -$11.3M | $5.6M | $3.2M | $21.7M | $26.1M | $29.8M |
| Net income | -$83.9M | $5.4M | -$4.3M | $28.0M | $26.7M | $27.0M |
| Net margin | −47.3% | 2.9% | −2.1% | 9.9% | 10.2% | 14.4% |
| Diluted EPS | $-2.01 | $0.13 | $-0.11 | $0.71 | $0.87 | $1.01 |
| EBITDA | -$9.2M | $7.7M | $5.4M | $22.9M | $26.9M | $30.2M |
| Operating cash flow | $10.1M | $9.4M | $14.5M | $8.3M | $18.3M | $23.8M |
| Free cash flow | $10.0M | $9.3M | $14.4M | $8.0M | $18.1M | $23.7M |
| Diluted shares | 41.8M | 41.6M | 40.6M | 39.3M | 30.8M | 26.8M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $44.0M | $34.6M | $29.0M | $25.4M | $37.8M | $34.4M |
| Short-term investments | $1.2M | $5.2M | $4.5M | $5.9M | $6.1M | — |
| Total debt | $0.00 | $0.00 | $0.00 | $724.9K | $0.00 | $0.00 |
| Total assets | $101.5M | $192.5M | $204.6M | $217.8M | $170.9M | $124.4M |
| Total liabilities | $16.7M | $30.1M | $42.2M | $49.2M | $43.9M | $54.0M |
| Shareholders' equity | $84.8M | $162.4M | $162.4M | $168.5M | $127.0M | $39.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology